<p>摩根大通（NYSE:SYK - 获取免费报告）在周四向投资者发布的报告中，将其目标股价从 400.00 美元下调至 392.00 美元，Benzinga 报道。该券商目前对这家医疗技术公司的股票给予 “持有” 评级。摩根大通的目标价格暗示该股当前价格有 8.98% 的上涨潜力。</p>
<ul>
<li>三家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
<p>其他几家股票研究分析师也最近对 SYK 发表了评论。Rothschild &amp; Co Redburn 在 9 月 18 日的报告中开始覆盖 Stryker。他们对该股设定了 “中性” 评级和 420.00 美元的目标价格。Redburn Partners 在 9 月 18 日的研究报告中对 Stryker 设定了 420.00 美元的目标价格。瑞银集团在 10 月 13 日的研究报告中对 Stryker 设定了 408.00 美元的目标价格。Evercore ISI 在 10 月 31 日的研究报告中将 Stryker 的目标价格从 410.00 美元下调至 405.00 美元，并对该公司给予 “跑赢大盘” 评级。最后，华尔街 Zen 在 12 月 13 日的报告中将 Stryker 的评级从 “买入” 下调至 “持有”。十二位股票研究分析师对该股给予了买入评级，六位分析师给予了持有评级。根据 MarketBeat.com 的数据，该股目前的共识评级为 “适度买入”，平均目标价格为 431.39 美元。</p>
<p><strong>获取我们关于 Stryker 的最新报告</strong></p>
<h2>Stryker 股票表现</h2>
<ul>
<li>为什么内部人士正在抛售 Robinhood、Stryker 和 Mercury Systems 的股票？</li>
</ul>
<p>周四，SYK 的股票在交易时段上涨了 7.13 美元，达到了 359.71 美元。该公司 381,748 股股票交易，较其平均交易量 1,457,759 股有所减少。Stryker 的十二个月低点为 329.16 美元，十二个月高点为 406.19 美元。该公司的 50 日简单移动平均为 365.79 美元，200 日简单移动平均为 377.86 美元。公司的债务与股本比率为 0.68，流动比率为 1.85，速动比率为 1.13。该公司的市值为 1375.6 亿美元，市盈率为 47.22，市盈增长比率为 2.49，贝塔值为 0.89。</p>
<p>摩根大通（NYSE:SYK - 获取免费报告）最近在 10 月 30 日发布了季度财报。这家医疗技术公司报告每股收益为 3.19 美元，超出市场共识预期的 3.13 美元，超出幅度为 0.06 美元。该公司在本季度的收入为 60.6 亿美元，而市场共识预期为 60.4 亿美元。Stryker 的净利润率为 12.07%，股本回报率为 24.07%。与去年同期相比，该公司的季度收入增长了 10.2%。在去年同期，该公司每股收益为 2.87 美元。Stryker 已将其 2025 财年的指导目标设定为每股收益 13.500-13.600 美元。分析师预测 Stryker 在当前年度的每股收益为 13.47 美元。</p>
<h2>Stryker 的内部交易</h2>
<ul>
<li>小心死亡交叉：3 只股票触发了这个可怕的信号</li>
</ul>
<p>在其他 Stryker 新闻中，董事 Ronda E. Stryker 在 11 月 6 日的交易中出售了 276,173 股公司的股票。该股票以平均价格 353.28 美元出售，总价值为 97,566,397.44 美元。出售完成后，该董事持有公司 2,702,108 股股票，价值约为 954,600,714.24 美元。此次交易使其持股减少了 9.27%。该出售在向证券交易委员会的备案中披露，相关文件可在此链接查看。此外，首席财务官 Preston Wendell Wells 在 11 月 20 日的交易中出售了 165 股股票。该股票以平均价格 365.88 美元出售，总价值为 60,370.20 美元。交易完成后，首席财务官持有公司 6,694 股股票，价值约为 2,449,200.72 美元。此次交易使其持股减少了 2.41%。有关此次出售的更多细节可在官方 SEC 披露中找到。内部人士在过去 90 天内共出售了 522,118 股公司股票，价值 185,381,932 美元。5.90% 的股票由内部人士持有。</p>
<h2>机构资金流入和流出</h2>
<p>一些对冲基金和其他机构投资者最近买卖了 SYK 的股票。Two Point Capital Management Inc.在第二季度购买了 Stryker 的新股份，价值约 728.1 万美元。Alecta Tjanstepension Omsesidigt 在第二季度将其在 Stryker 的持股增加了 82.0%。Alecta Tjanstepension Omsesidigt 现在拥有 458,300 股医疗技术公司的股票，价值 1.81235 亿美元，此前在上一季度又购买了 206,500 股。SVB Wealth LLC 在第二季度购买了 Stryker 的新股份，价值约 478.5 万美元。AXQ Capital LP 在第二季度收购了 Stryker 的新股份，价值约 567,000 美元。最后，联合服务汽车协会在第一季度收购了 Stryker 的新股份，价值 285.7 万美元。77.09% 的股票目前由机构投资者和对冲基金持有。</p>
<h2>关于 Stryker</h2>
<p>（获取免费报告）</p>
<p>Stryker Corporation 是一家医疗技术公司。该公司通过两个部门运营，分别是 MedSurg 和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更喜欢的股票超过 Stryker</li>
<li>恒生指数是什么？</li>
<li>美光第一季度业绩表明 “人工智能泡沫远未破裂”</li>
<li>股票市场指数是什么，如何使用它们？</li>
<li>3 只便宜的股息股票可以战胜通货膨胀并支付你等待的费用</li>
<li>何时出售股票以获利或亏损</li>
<li>3 只新年决议股票可能在 2026 年反弹</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在史赛克吗？</h2>
<p>在考虑史赛克之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而史赛克并不在名单上。</p>
<p>虽然史赛克目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

史赛克

<p>Truist Financial 将史赛克的目标价格从 400 美元下调至 392 美元，维持 “持有” 评级。分析师们的意见不一，目标价格范围在 405 美元到 420 美元之间。史赛克的股票共识评级为 “适度买入”，平均目标价格为 431.39 美元。最近注意到内部人士的销售和机构交易，内部人士在过去 90 天内出售了价值 1.85 亿美元的 522,118 股股票</p>

<p>Stryker (NYSE:SYK - Get Free Report) had its price target cut by stock analysts at Truist Financial from $400.00 to $392.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has a &#34;hold&#34; rating on the medical technology company's stock. Truist Financial's target price suggests a potential upside of 8.98% from the stock's current price.</p>
<div class="lb-trans"><p>摩根大通（NYSE:SYK - 获取免费报告）在周四向投资者发布的报告中，将其目标股价从 400.00 美元下调至 392.00 美元，Benzinga 报道。该券商目前对这家医疗技术公司的股票给予 “持有” 评级。摩根大通的目标价格暗示该股当前价格有 8.98% 的上涨潜力。</p>
</div><ul>
<li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li>
</ul>
<div class="lb-trans"><ul>
<li>三家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
</div><p>Several other equities research analysts have also recently commented on SYK. Rothschild &amp; Co Redburn assumed coverage on Stryker in a report on Thursday, September 18th. They set a &#34;neutral&#34; rating and a $420.00 target price on the stock. Redburn Partners set a $420.00 price target on Stryker in a research report on Thursday, September 18th. UBS Group set a $408.00 price target on Stryker in a research note on Monday, October 13th. Evercore ISI reduced their price objective on shares of Stryker from $410.00 to $405.00 and set an &#34;outperform&#34; rating for the company in a research note on Friday, October 31st. Finally, Wall Street Zen cut shares of Stryker from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, December 13th. Twelve equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $431.39.</p>
<div class="lb-trans"><p>其他几家股票研究分析师也最近对 SYK 发表了评论。Rothschild &amp; Co Redburn 在 9 月 18 日的报告中开始覆盖 Stryker。他们对该股设定了 “中性” 评级和 420.00 美元的目标价格。Redburn Partners 在 9 月 18 日的研究报告中对 Stryker 设定了 420.00 美元的目标价格。瑞银集团在 10 月 13 日的研究报告中对 Stryker 设定了 408.00 美元的目标价格。Evercore ISI 在 10 月 31 日的研究报告中将 Stryker 的目标价格从 410.00 美元下调至 405.00 美元，并对该公司给予 “跑赢大盘” 评级。最后，华尔街 Zen 在 12 月 13 日的报告中将 Stryker 的评级从 “买入” 下调至 “持有”。十二位股票研究分析师对该股给予了买入评级，六位分析师给予了持有评级。根据 MarketBeat.com 的数据，该股目前的共识评级为 “适度买入”，平均目标价格为 431.39 美元。</p>
</div><p><strong>Get Our Latest Report on Stryker</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Stryker 的最新报告</strong></p>
</div><h2>Stryker Stock Performance</h2>
<div class="lb-trans"><h2>Stryker 股票表现</h2>
</div><ul>
<li>Why Are Insiders Are Dumping Shares of Robinhood, Stryker, and Mercury Systems?</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么内部人士正在抛售 Robinhood、Stryker 和 Mercury Systems 的股票？</li>
</ul>
</div><p>Shares of SYK traded up $7.13 during trading hours on Thursday, reaching $359.71. 381,748 shares of the company's stock traded hands, compared to its average volume of 1,457,759. Stryker has a twelve month low of $329.16 and a twelve month high of $406.19. The business's fifty day simple moving average is $365.79 and its two-hundred day simple moving average is $377.86. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.85 and a quick ratio of 1.13. The firm has a market capitalization of $137.56 billion, a price-to-earnings ratio of 47.22, a P/E/G ratio of 2.49 and a beta of 0.89.</p>
<div class="lb-trans"><p>周四，SYK 的股票在交易时段上涨了 7.13 美元，达到了 359.71 美元。该公司 381,748 股股票交易，较其平均交易量 1,457,759 股有所减少。Stryker 的十二个月低点为 329.16 美元，十二个月高点为 406.19 美元。该公司的 50 日简单移动平均为 365.79 美元，200 日简单移动平均为 377.86 美元。公司的债务与股本比率为 0.68，流动比率为 1.85，速动比率为 1.13。该公司的市值为 1375.6 亿美元，市盈率为 47.22，市盈增长比率为 2.49，贝塔值为 0.89。</p>
</div><p>Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, topping the consensus estimate of $3.13 by $0.06. The business had revenue of $6.06 billion during the quarter, compared to the consensus estimate of $6.04 billion. Stryker had a net margin of 12.07% and a return on equity of 24.07%. The company's quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.87 earnings per share. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. Analysts predict that Stryker will post 13.47 earnings per share for the current year.</p>
<div class="lb-trans"><p>摩根大通（NYSE:SYK - 获取免费报告）最近在 10 月 30 日发布了季度财报。这家医疗技术公司报告每股收益为 3.19 美元，超出市场共识预期的 3.13 美元，超出幅度为 0.06 美元。该公司在本季度的收入为 60.6 亿美元，而市场共识预期为 60.4 亿美元。Stryker 的净利润率为 12.07%，股本回报率为 24.07%。与去年同期相比，该公司的季度收入增长了 10.2%。在去年同期，该公司每股收益为 2.87 美元。Stryker 已将其 2025 财年的指导目标设定为每股收益 13.500-13.600 美元。分析师预测 Stryker 在当前年度的每股收益为 13.47 美元。</p>
</div><h2>Insider Transactions at Stryker</h2>
<div class="lb-trans"><h2>Stryker 的内部交易</h2>
</div><ul>
<li>Beware the Death Cross: 3 Stocks Triggering This Spooky Signal</li>
</ul>
<div class="lb-trans"><ul>
<li>小心死亡交叉：3 只股票触发了这个可怕的信号</li>
</ul>
</div><p>In other Stryker news, Director Ronda E. Stryker sold 276,173 shares of the business's stock in a transaction dated Thursday, November 6th. The stock was sold at an average price of $353.28, for a total value of $97,566,397.44. Following the completion of the sale, the director owned 2,702,108 shares of the company's stock, valued at $954,600,714.24. The trade was a 9.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. Also, CFO Preston Wendell Wells sold 165 shares of the stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $365.88, for a total value of $60,370.20. Following the transaction, the chief financial officer owned 6,694 shares in the company, valued at approximately $2,449,200.72. This trade represents a 2.41% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 522,118 shares of company stock worth $185,381,932 in the last 90 days. 5.90% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他 Stryker 新闻中，董事 Ronda E. Stryker 在 11 月 6 日的交易中出售了 276,173 股公司的股票。该股票以平均价格 353.28 美元出售，总价值为 97,566,397.44 美元。出售完成后，该董事持有公司 2,702,108 股股票，价值约为 954,600,714.24 美元。此次交易使其持股减少了 9.27%。该出售在向证券交易委员会的备案中披露，相关文件可在此链接查看。此外，首席财务官 Preston Wendell Wells 在 11 月 20 日的交易中出售了 165 股股票。该股票以平均价格 365.88 美元出售，总价值为 60,370.20 美元。交易完成后，首席财务官持有公司 6,694 股股票，价值约为 2,449,200.72 美元。此次交易使其持股减少了 2.41%。有关此次出售的更多细节可在官方 SEC 披露中找到。内部人士在过去 90 天内共出售了 522,118 股公司股票，价值 185,381,932 美元。5.90% 的股票由内部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of hedge funds and other institutional investors have recently bought and sold shares of SYK. Two Point Capital Management Inc. bought a new stake in Stryker during the second quarter worth about $7,281,000. Alecta Tjanstepension Omsesidigt lifted its position in Stryker by 82.0% during the 2nd quarter. Alecta Tjanstepension Omsesidigt now owns 458,300 shares of the medical technology company's stock worth $181,235,000 after buying an additional 206,500 shares in the last quarter. SVB Wealth LLC bought a new stake in Stryker during the 2nd quarter worth about $4,785,000. AXQ Capital LP acquired a new stake in shares of Stryker in the second quarter valued at approximately $567,000. Finally, United Services Automobile Association acquired a new stake in shares of Stryker in the 1st quarter valued at $2,857,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些对冲基金和其他机构投资者最近买卖了 SYK 的股票。Two Point Capital Management Inc.在第二季度购买了 Stryker 的新股份，价值约 728.1 万美元。Alecta Tjanstepension Omsesidigt 在第二季度将其在 Stryker 的持股增加了 82.0%。Alecta Tjanstepension Omsesidigt 现在拥有 458,300 股医疗技术公司的股票，价值 1.81235 亿美元，此前在上一季度又购买了 206,500 股。SVB Wealth LLC 在第二季度购买了 Stryker 的新股份，价值约 478.5 万美元。AXQ Capital LP 在第二季度收购了 Stryker 的新股份，价值约 567,000 美元。最后，联合服务汽车协会在第一季度收购了 Stryker 的新股份，价值 285.7 万美元。77.09% 的股票目前由机构投资者和对冲基金持有。</p>
</div><h2>About Stryker</h2>
<div class="lb-trans"><h2>关于 Stryker</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.</p>
<div class="lb-trans"><p>Stryker Corporation 是一家医疗技术公司。该公司通过两个部门运营，分别是 MedSurg 和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Stryker</li>
<li>What is the Hang Seng index?</li>
<li>Micron’s Q1 Results Say “AI Bubble Is Far From Bursting”</li>
<li>What is a Stock Market Index and How Do You Use Them?</li>
<li>3 Cheap Dividend Stocks That Can Beat Inflation and Pay You to Wait</li>
<li>When to Sell a Stock for Profit or Loss</li>
<li>3 New Year’s Resolution Stocks That Could Turn Around in 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更喜欢的股票超过 Stryker</li>
<li>恒生指数是什么？</li>
<li>美光第一季度业绩表明 “人工智能泡沫远未破裂”</li>
<li>股票市场指数是什么，如何使用它们？</li>
<li>3 只便宜的股息股票可以战胜通货膨胀并支付你等待的费用</li>
<li>何时出售股票以获利或亏损</li>
<li>3 只新年决议股票可能在 2026 年反弹</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=SYK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Stryker Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在史赛克吗？</h2>
</div><p>Before you consider Stryker, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑史赛克之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而史赛克并不在名单上。</p>
</div><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然史赛克目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Truist Financial 下调了对史赛克（NYSE:SYK）股票价格的预期